Abstract
Testing and case identification are key strategies in controlling the COVID-19 pandemic. Contact tracing and isolation are only possible if cases have been identified. The effectiveness of testing must be tracked, but a single comprehensive metric is not available to assess testing effectiveness, and no timely estimates of case detection rate are available globally, making inter-country comparisons difficult. The purpose of this paper was to propose a single, comprehensive metric, called the COVID-19 Testing Index (CovTI) scaled from 0 to 100, that incorporated several testing metrics. The index was based on case-fatality rate, test positivity rate, active cases, and an estimate of the detection rate. It used parsimonious modeling to estimate the true total number of COVID-19 cases based on deaths, testing, health system capacity, and government transparency. Publicly reported data from 188 countries and territories were included in the index. Estimates of detection rates aligned with previous estimates in literature (R2=0.97). As of June 3, 2020, the states with the highest CovTI included Iceland, Australia, New Zealand, Hong Kong, and Thailand, and some island nations. Globally, CovTI increased from April 20 to June 3 but declined in ca. 10% of countries. Bivariate analyses showed the average in countries with open public testing policies (59.7, 95% CI 55.6-63.8) were significantly higher than countries with no testing policy (30.2, 95% CI 18.1-42.3) (p<0.0001). A multiple linear regression model assessed the association of independent grouping variables with CovTI. Open public testing and extensive contact tracing were shown to significantly increase CovTI, after adjusting for extrinsic factors, including geographic isolation and centralized forms of government. This tool may be useful for policymakers to assess testing effectiveness, inform decisions, and identify model countries. It may also serve as a tool for researchers in analyses by combining it with other databases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
None required.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Our data was obtained from publicly available data, including: Worldometer COVID-19 (April 20, 2020 and June 3, 2020) (https://www.worldometers.info/coronavirus/) provided data on Total Cases, Total Deaths, Total Recovered cases, Active Cases, Total Tests and population. The Economist Intelligence Unit Democracy Index (2019) (https://www.eiu.com/topic/democracy-index) provided data for the Democracy Index. Global Health Security Index (October 2019) (https://www.ghsindex.org/report-model/) provided data for the Detection and Reporting Country Score. Oxford Coronavirus Government Response Tracker (May 13, 2020) (https://ourworldindata.org/grapher/covid-19-testing-policy, https://ourworldindata.org/grapher/covid-contact-tracing) provided data on COVID-19 Testing Policies, which countries do COVID-19 contact tracing? A complete table of our June 3, 2020 dataset is reported in Supplementary Material S1 Table. The full dataset that was analyzed and reported in Supplementary Material S2 Table and is available by request. A complete dataset, including historical data that was not analyzed in this paper, can also be made available.
https://www.worldometers.info/coronavirus/
https://www.eiu.com/topic/democracy-index
https://www.ghsindex.org/report-model/